No abstract available
MeSH terms
-
Aged
-
Aged, 80 and over
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Biphenyl Compounds / adverse effects
-
Biphenyl Compounds / therapeutic use
-
Bone Density Conservation Agents / adverse effects
-
Bone Density Conservation Agents / therapeutic use*
-
Calcium, Dietary / administration & dosage
-
Cause of Death
-
Combined Modality Therapy
-
Cross-Sectional Studies
-
Denosumab
-
Diphosphonates / adverse effects
-
Diphosphonates / therapeutic use
-
Female
-
Germany
-
Humans
-
Life Style
-
Male
-
Middle Aged
-
Osteoporosis / drug therapy*
-
Osteoporosis / epidemiology
-
Osteoporosis / mortality
-
Osteoporosis / prevention & control
-
Osteoporotic Fractures / epidemiology
-
Osteoporotic Fractures / mortality
-
Osteoporotic Fractures / prevention & control
-
Population Dynamics
-
Risk Factors
-
Selective Estrogen Receptor Modulators / adverse effects
-
Selective Estrogen Receptor Modulators / therapeutic use
-
Vitamin D / administration & dosage
Substances
-
Antibodies, Monoclonal, Humanized
-
Biphenyl Compounds
-
Bone Density Conservation Agents
-
Calcium, Dietary
-
Diphosphonates
-
Selective Estrogen Receptor Modulators
-
Vitamin D
-
Denosumab
-
odanacatib